Efficient gene transfer into primitive hematopoietic progenitors using a bone marrow microenvironment cell line engineered to produce retroviral vectors

Jonathan S. Dando, Francesca Ficara, Sara Deola, Maria Grazia Roncarolo, Claudio Bordignon, Alessandro Aiuti

Research output: Contribution to journalArticle

Abstract

Background and Objectives. Effective gene transfer into human hematopoietic stem/progenitor cells is a compromise between achieving high transduction efficiency and maintaining the desired biological characteristics of the target cell. The aim of our work was to exploit the stromal microenvironment to increase gene transfer and maintenance of hematopoietic progenitors. Design and Methods. The murine bone marrow stromal cell line MS-5, known to support primitive human progenitors, was modified into an amphotropic packaging cell, by the stable introduction of DNA coding for retroviral structural proteins, and a viral vector encoding a marker gene. The gene transfer efficiency of the recombinant virus was evaluated by flow cytometry, in vitro assays for committed (CFC) and primitive (LTC-CFC) progenitors, as well as a clonal assay for B and NK lymphoid progenitors. Results. The new packaging cell line (NEXUS) produced equivalent levels of virus as did the established GP+AM 12 system, also under serum-free conditions. On average 30% of human mobilized peripheral blood CD34+ cells were transduced by a single exposure to NEXUS supernatant, representing a three-fold increase over GP+Am 12-based technology. Gene transfer into both committed and primitive progenitors increased on average two-fold using NEXUS retroviral supernatant. Furthermore, CD34 +CD38low early progenitor cells purified from umbilical cord blood were efficiently transduced with NEXUS retroviral vector and gave rise to a high frequency of marked B and NK lymphocytes. Interpretation and Conclusions. Our data show that that an established bone marrow stromal cell can be engineered to enhance the genetic modification of primitive hematopoietic and lymphoid progenitors using a clinically relevant method.

Original languageEnglish
Pages (from-to)462-470
Number of pages9
JournalHaematologica
Volume89
Issue number4
Publication statusPublished - 1 Apr 2004
Externally publishedYes

Fingerprint

Bone Marrow Cells
Cell Line
Genes
Product Packaging
Hematopoietic Stem Cells
Mesenchymal Stromal Cells
Viruses
Viral Structural Proteins
Fetal Blood
Blood Cells
Flow Cytometry
Stem Cells
Maintenance
Lymphocytes
Technology
DNA
Serum

Keywords

  • CD34 cells
  • Gene therapy
  • Packaging cell
  • Stromal cell

ASJC Scopus subject areas

  • Hematology

Cite this

Efficient gene transfer into primitive hematopoietic progenitors using a bone marrow microenvironment cell line engineered to produce retroviral vectors. / Dando, Jonathan S.; Ficara, Francesca; Deola, Sara; Roncarolo, Maria Grazia; Bordignon, Claudio; Aiuti, Alessandro.

In: Haematologica, Vol. 89, No. 4, 01.04.2004, p. 462-470.

Research output: Contribution to journalArticle

Dando, Jonathan S. ; Ficara, Francesca ; Deola, Sara ; Roncarolo, Maria Grazia ; Bordignon, Claudio ; Aiuti, Alessandro. / Efficient gene transfer into primitive hematopoietic progenitors using a bone marrow microenvironment cell line engineered to produce retroviral vectors. In: Haematologica. 2004 ; Vol. 89, No. 4. pp. 462-470.
@article{552a28fff67648a68aa44b7e387fa22c,
title = "Efficient gene transfer into primitive hematopoietic progenitors using a bone marrow microenvironment cell line engineered to produce retroviral vectors",
abstract = "Background and Objectives. Effective gene transfer into human hematopoietic stem/progenitor cells is a compromise between achieving high transduction efficiency and maintaining the desired biological characteristics of the target cell. The aim of our work was to exploit the stromal microenvironment to increase gene transfer and maintenance of hematopoietic progenitors. Design and Methods. The murine bone marrow stromal cell line MS-5, known to support primitive human progenitors, was modified into an amphotropic packaging cell, by the stable introduction of DNA coding for retroviral structural proteins, and a viral vector encoding a marker gene. The gene transfer efficiency of the recombinant virus was evaluated by flow cytometry, in vitro assays for committed (CFC) and primitive (LTC-CFC) progenitors, as well as a clonal assay for B and NK lymphoid progenitors. Results. The new packaging cell line (NEXUS) produced equivalent levels of virus as did the established GP+AM 12 system, also under serum-free conditions. On average 30{\%} of human mobilized peripheral blood CD34+ cells were transduced by a single exposure to NEXUS supernatant, representing a three-fold increase over GP+Am 12-based technology. Gene transfer into both committed and primitive progenitors increased on average two-fold using NEXUS retroviral supernatant. Furthermore, CD34 +CD38low early progenitor cells purified from umbilical cord blood were efficiently transduced with NEXUS retroviral vector and gave rise to a high frequency of marked B and NK lymphocytes. Interpretation and Conclusions. Our data show that that an established bone marrow stromal cell can be engineered to enhance the genetic modification of primitive hematopoietic and lymphoid progenitors using a clinically relevant method.",
keywords = "CD34 cells, Gene therapy, Packaging cell, Stromal cell",
author = "Dando, {Jonathan S.} and Francesca Ficara and Sara Deola and Roncarolo, {Maria Grazia} and Claudio Bordignon and Alessandro Aiuti",
year = "2004",
month = "4",
day = "1",
language = "English",
volume = "89",
pages = "462--470",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "4",

}

TY - JOUR

T1 - Efficient gene transfer into primitive hematopoietic progenitors using a bone marrow microenvironment cell line engineered to produce retroviral vectors

AU - Dando, Jonathan S.

AU - Ficara, Francesca

AU - Deola, Sara

AU - Roncarolo, Maria Grazia

AU - Bordignon, Claudio

AU - Aiuti, Alessandro

PY - 2004/4/1

Y1 - 2004/4/1

N2 - Background and Objectives. Effective gene transfer into human hematopoietic stem/progenitor cells is a compromise between achieving high transduction efficiency and maintaining the desired biological characteristics of the target cell. The aim of our work was to exploit the stromal microenvironment to increase gene transfer and maintenance of hematopoietic progenitors. Design and Methods. The murine bone marrow stromal cell line MS-5, known to support primitive human progenitors, was modified into an amphotropic packaging cell, by the stable introduction of DNA coding for retroviral structural proteins, and a viral vector encoding a marker gene. The gene transfer efficiency of the recombinant virus was evaluated by flow cytometry, in vitro assays for committed (CFC) and primitive (LTC-CFC) progenitors, as well as a clonal assay for B and NK lymphoid progenitors. Results. The new packaging cell line (NEXUS) produced equivalent levels of virus as did the established GP+AM 12 system, also under serum-free conditions. On average 30% of human mobilized peripheral blood CD34+ cells were transduced by a single exposure to NEXUS supernatant, representing a three-fold increase over GP+Am 12-based technology. Gene transfer into both committed and primitive progenitors increased on average two-fold using NEXUS retroviral supernatant. Furthermore, CD34 +CD38low early progenitor cells purified from umbilical cord blood were efficiently transduced with NEXUS retroviral vector and gave rise to a high frequency of marked B and NK lymphocytes. Interpretation and Conclusions. Our data show that that an established bone marrow stromal cell can be engineered to enhance the genetic modification of primitive hematopoietic and lymphoid progenitors using a clinically relevant method.

AB - Background and Objectives. Effective gene transfer into human hematopoietic stem/progenitor cells is a compromise between achieving high transduction efficiency and maintaining the desired biological characteristics of the target cell. The aim of our work was to exploit the stromal microenvironment to increase gene transfer and maintenance of hematopoietic progenitors. Design and Methods. The murine bone marrow stromal cell line MS-5, known to support primitive human progenitors, was modified into an amphotropic packaging cell, by the stable introduction of DNA coding for retroviral structural proteins, and a viral vector encoding a marker gene. The gene transfer efficiency of the recombinant virus was evaluated by flow cytometry, in vitro assays for committed (CFC) and primitive (LTC-CFC) progenitors, as well as a clonal assay for B and NK lymphoid progenitors. Results. The new packaging cell line (NEXUS) produced equivalent levels of virus as did the established GP+AM 12 system, also under serum-free conditions. On average 30% of human mobilized peripheral blood CD34+ cells were transduced by a single exposure to NEXUS supernatant, representing a three-fold increase over GP+Am 12-based technology. Gene transfer into both committed and primitive progenitors increased on average two-fold using NEXUS retroviral supernatant. Furthermore, CD34 +CD38low early progenitor cells purified from umbilical cord blood were efficiently transduced with NEXUS retroviral vector and gave rise to a high frequency of marked B and NK lymphocytes. Interpretation and Conclusions. Our data show that that an established bone marrow stromal cell can be engineered to enhance the genetic modification of primitive hematopoietic and lymphoid progenitors using a clinically relevant method.

KW - CD34 cells

KW - Gene therapy

KW - Packaging cell

KW - Stromal cell

UR - http://www.scopus.com/inward/record.url?scp=2942722246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942722246&partnerID=8YFLogxK

M3 - Article

C2 - 15075080

AN - SCOPUS:2942722246

VL - 89

SP - 462

EP - 470

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 4

ER -